Ovid Therapeutics Q3 EPS $(0.10) Misses $(0.09) Estimate
Benzinga Newsdesk 20 hours ago
NewsEarningsEarnings Misses
Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 41.18 percent increase over losses of $(0.17) per share
Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 41.18 percent increase over losses of $(0.17) per share from the same period last year.